Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for Cue Biopharma (CUE) over the last 8 years, with Q2 2025 value amounting to $27000.0.

  • Cue Biopharma's Capital Expenditures rose 17000.0% to $27000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $179000.0, marking a year-over-year increase of 17968.75%. This contributed to the annual value of $66000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Cue Biopharma's Capital Expenditures is $27000.0, which was up 17000.0% from $150000.0 recorded in Q1 2025.
  • In the past 5 years, Cue Biopharma's Capital Expenditures registered a high of $648000.0 during Q1 2021, and its lowest value of -$1000.0 during Q3 2024.
  • Moreover, its 4-year median value for Capital Expenditures was $27000.0 (2022), whereas its average is $94788.5.
  • Per our database at Business Quant, Cue Biopharma's Capital Expenditures plummeted by 9996.4% in 2021 and then soared by 246410.26% in 2022.
  • Cue Biopharma's Capital Expenditures (Quarter) stood at $39.0 in 2021, then skyrocketed by 2464.1% to $1000.0 in 2022, then surged by 100.0% to $2000.0 in 2024, then skyrocketed by 1250.0% to $27000.0 in 2025.
  • Its Capital Expenditures was $27000.0 in Q2 2025, compared to $150000.0 in Q1 2025 and $2000.0 in Q4 2024.